Pipelinepharma, a European B2B pharmaceutical marketplace, closed a venture seed round led by Practica Capital. The marketplace has facilitated pharmaceutical product licensing, supply, acquisition deals of more than €200 million in value, covering more than 30 markets on five continents. The investment will help attract talent to… Read More
In DDW and ELRIG UK's Drug Discovery 2021 supplement, CEO and Founder of Egality Health, Annette Crosse, offers insight into the importance of diversity in clinical trials and of overcoming limitations in healthcare research to re-imagine a system which provides safe, effective and innovative therapies for the entire population. Annette Crosse describes… Read More
The Fall Issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & ELRIG UK supplement ahead of ELRIG UK’s Drug Discovery 2021 in Liverpool, October 19-20, 2021. In it, ELRIG UK’s General Manager Sanj Kumar welcomes the event and introduces the themes. In 2019, ELRIG’s flagship scientific… Read More
Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More
PharmaLex Group has announced the launch of a new service line, Biopharma Excellence, and the appointment of ex-MHRA scientific lead Dr Christian Schneider as its Chief Medical Officer. Biopharma Excellence is a fusion of three scientific organisations, PharmaLex, ERA Consulting and Biopharma Excellence, under the PharmaLex brand. The new service line combines 35+ years of… Read More
Imophoron, the Bristol-based developer of a rapid-response vaccine platform, ADDomer, has secured £4 million in an oversubscribed fundraising round. Frederic Garzoni, CEO and Co-founder of Imophoron, said: “It has now been demonstrated how a pandemic cannot just threaten lives, but our society and economy as we know it. Imophoron is developing its ADDomer vaccine platform… Read More
Scientists revealed in a new study how gut bacteria contribute to the progression of advanced prostate cancers and their resistance to hormone therapy by providing an alternative source of growth-promoting androgens, or male hormones. Hormone therapy is the standard of care for advanced prostate cancer and works… Read More
The Fall Issue of the Drug Discovery World Magazine is accompanied by an exclusive DDW & ELRIG UK supplement ahead of ELRIG UK’s Drug Discovery 2021 in Liverpool, October 19-20, 2021. DDW Editor Lu Rahman welcomes the event and introduces the themes. To say that I – as well as the entire… Read More
In 18 months, vaccine research advanced AI in medicine by five to seven years. That’s cause for optimism — and investment — in the digital transformation of clinical development. Jeff Elton, CEO of ConcertAI, who has extensive experience in this sector, shares his insight with DDW. There has been a… Read More
Sygnature Discovery will be presenting a workshop at ELRIG UK’s Drug Discovery 2021 event entitled, Gaining a career in industry: Learning tips and tricks from the inside. It will take place on the first day of Drug Discovery 2021 in Liverpool, from 10.50 – 11.50am in Room 11B. … Read More
Crown Bioscience has launched its ‘3D Ex Vivo Patient Tissue Platform’ which, using freshly collected patient tumour material, can accurately measure oncology and immuno-oncology drug-induced tumour killing and endogenous immune cell proliferation in a high throughput format. Researchers presented data on the new platform at 2021’s AACR-NCI-EORTC International Conference on Molecular Targets and… Read More
This On Demand webinar by Olink features Bill Hunt, Director of Product Management at Fluidigm, and Dr Jenny Rubin, Development Engineer at Olink Proteomics. The webinar examines the new Olink Signature Q100, a benchtop system for protein biomarker analysis. Hunt discusses “Signature Q100 System – Evolution of workhorse for protein expression”, while Rubin… Read More
The 2021 Nobel Prize in Physiology or Medicine has been jointly awarded to David Julius and Ardem Patapoutian for their discoveries of receptors for temperature and touch. David Julius utilised capsaicin, a compound from chili peppers that induces a burning sensation, to identify a sensor in the nerve endings of the skin that responds… Read More
Human synthetic biology enterprise bit.bio will be exhibiting, hosting a workshop and presenting at ELRIG UK’s Drug Discovery 2021, held at ACC Liverpool from October 19-20, 2021. The company will be exhibiting at booth B16/B9, where visitors are able to learn about bit.bio’s mature, functional human… Read More
Galapagos presented data at the United European Gastroenterology Week (UEGW) virtual 2021 congress, which suggests patients with ulcerative colitis (UC) treated with early advanced therapy within the first 18 months post diagnosis showed less residual diarrhoea and required fewer follow-up tests than those who were treated with an advanced therapy later. Results… Read More
Evotec has expanded its collaboration with Bristol Myers Squibb to include a new cell type. The collaboration was initiated in December 2016 with the goal of identifying disease-modifying treatments for a broad range of neurodegenerative diseases. Currently approved drugs only offer short-term management of the patients’… Read More
